12:20 PM EST - Optimind Pharma Corp : Announces today its acquisition of MindSetting Institute, a leader in psychedelic enhanced therapy training and educational programming. The completion of this acquisition introduces a new market opportunity for Optimind which will generate new revenue streams and allows the Company to bring evidence-based training and education for healthcare professionals into the psychedelics. Optimind Pharma Corp
shares C.OMND are trading unchanged at $0.07.
